Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2003
07/16/2003CN1429594A Raw material in plant for regulating blood sugar extracted by using super critical CO2 extraction method and its preparation method
07/16/2003CN1429591A Fat reducing liver protecting capsule
07/16/2003CN1429576A Edible fungus formula for treating hypertension and diabetes and its preparation method
07/16/2003CN1429572A Chinese patent drug for treating diabetes
07/16/2003CN1429551A Treating diabetes by thiazolidine-diketo and dimethylbiguanide
07/16/2003CN1429502A Pueraria root beverage
07/16/2003CN1429492A Balsam pear saccharide capable of regulating blood sugar and its production process
07/16/2003CN1114618C Trivalent chromium compound, its milk product and making process
07/16/2003CN1114597C Quinoline derivs
07/16/2003CN1114438C Application of stable rice sugar derivative-treated by enzyme
07/16/2003CN1114425C Chinese patent medicine for treating coronary heart disease and hypertension
07/16/2003CN1114421C Chinese medicine for treating diabetes
07/16/2003CN1114404C Treatment of diabetes with thiazolidinedione and melbine
07/16/2003CN1114346C Hypoglycemic soybean fiber powder
07/15/2003US6593493 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes
07/15/2003US6593480 Obesity, hyperglycemia
07/15/2003US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis
07/15/2003US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593350 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593345 Naphthyl compounds, intermediates, compositions, and methods of use
07/15/2003US6593330 Compounds and their use
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6593323 Benzimidazole compounds and drugs containing the same
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/15/2003US6593312 Cyclic α-amino-γ-hydroxyamide compounds
07/15/2003US6593295 Long lasting insulinotropic peptides
07/15/2003US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6592911 (−)-Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum
07/15/2003US6592910 Methods of treating clinical diseases with isoflavones
07/15/2003US6592901 Highly compressible ethylcellulose for tableting
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/15/2003US6592860 Composition and applicator for topical substance delivery
07/15/2003CA2218766C Bicyclic-aromatic compounds
07/15/2003CA2095889C Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
07/10/2003WO2003056029A2 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate
07/10/2003WO2003056005A1 Human sglt homolog promoter and use thereof
07/10/2003WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
07/10/2003WO2003055883A1 Pyrimidotriazines as phosphatase inhibitors
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055881A1 Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors
07/10/2003WO2003055880A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055865A1 Quinazolinone derivative
07/10/2003WO2003055854A1 2-substituted vitamin d derivatives
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055523A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/10/2003WO2003055509A1 Agonists and antagonists of bromix for the treatment of metabolic disorders
07/10/2003WO2003055507A1 Remedies for anorexia or lifestyle-related diseases and method of screening the same
07/10/2003WO2003055487A1 METHOD OF CONTROLLING DAMAGE MEDIATED BY α, β- UNSATURATED ALDEHYDES
07/10/2003WO2003055485A1 Dosing regimen for ppar-gamma activators
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003WO2003055477A1 Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
07/10/2003WO2003055456A1 Stable surfactant compositions for suspending components
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055335A1 Modified methionine rich food products and process for their manufacture
07/10/2003WO2003055324A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
07/10/2003WO2003011227A3 Taste masking composition
07/10/2003WO2002101392A3 Methods for treating disorders of the nervous and reproductive systems
07/10/2003WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002059278A3 Differentiation of stem cells to pancreatic endocrine cells
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002038166A3 Ginseng berry extracts and pharmaceutical compositions therefrom
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2002013759A3 Method of treating the syndrome of type 2 diabetes in humans
07/10/2003WO2002009761A9 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001089550A3 Use of ciliary neurotrophic factor
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130352 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis
07/10/2003US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
07/10/2003US20030130335 Protein tyrosine phosphatases inhibitors
07/10/2003US20030130332 Method for prophylaxis and treatment of diabetic complications with 4[alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives
07/10/2003US20030130323 Anorectic agents
07/10/2003US20030130296 FXR NR1H4 nuclear receptor binding compounds
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130281 DPP IV inhibitors
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130274 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
1 ... 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 ... 1298